We use cookies to ensure you get the best experience on our website. By continuing to browse, you agree to our use of cookies and our Privacy Policy
Tag: Oncology
$1 Million Funding Boost Advances Research into Novel B...
New $1 million funding supports advanced research into novel brain cancer treatm...
Noninvasive Urine Test Shows Promise in Predicting Blad...
A new noninvasive urine test may improve prediction of bladder cancer treatment ...
Gilead to Acquire Germany’s Tubulis for Up to $5 Billio...
Gilead Sciences will acquire German biotech firm Tubulis for up to $5 billion to...
TGH Cancer Institute and USF Health to Host Symposium o...
TGH Cancer Institute and USF Health Morsani College of Medicine will host a 2026...
Actinium Pharmaceuticals to Present Promising Pan-Tumor...
Actinium Pharmaceuticals will present new preclinical data on ATNM-400 showing p...
Cancer Drug Makers Seek Up to 50% Price Increase Amid S...
Cancer drug manufacturers are seeking up to a 50% price increase as rising plati...
COCOON Trial Protocol Cuts Skin Toxicities by Half in L...
A new COCOON trial protocol has been shown to reduce skin toxicities by 50% in l...
New Dual-Drug Approach Shows Potential to Eliminate Tum...
Researchers report that a new dual-drug strategy combined with immunotherapy may...
Researchers Establish New Global Standards for Studying...
International researchers have introduced new standards for studying tumor micro...
NCCN Conference Highlights New Strategies to Advance Gl...
Experts at the NCCN conference unveiled new global cancer care strategies aimed ...
PSMA Therapy May Delay Hormone Treatment in Prostate Ca...
A new study suggests PSMA-targeted therapy may delay the need for hormone treatm...
Breakthrough Therapies Drive Innovation in Head and Nec...
Advances in breakthrough therapies are transforming the treatment landscape for ...
New Leukemia Study Highlights Role of Key Gene Failure ...
A new leukemia study reveals how failure of a key gene influences disease progre...
Corcept Therapeutics Secures US FDA Approval for Ovaria...
Corcept Therapeutics has received US FDA approval for its ovarian cancer treatme...
Merck to Acquire Terns Pharma in $6.7 Billion Deal to E...
Merck announces a $6.7 billion acquisition of Terns Pharma to strengthen its can...
New Study Explores Advances in Oncology Treatment Strat...
A new oncology study highlights emerging treatment strategies and their impact o...